Chemotherapy with cisplatin and paclitaxel in patients with locally advanced, recurrent or metastatic oesophageal cancer

British Journal of Cancer

Volumn 78, Issue 4, 1998, Pages 511-514

  Petrasch, S ^a   Welt, A ^b   Reinacher, A ^a   Graeven, U ^a   Konig M ^a   Schmiegel, W ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Cisplatin; Oesophageal cancer; Paclitaxel

Indexed keywords

CISPLATIN; PACLITAXEL;

ADENOCARCINOMA; ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ARTICLE; CANCER REGRESSION; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; ESOPHAGUS CANCER; ESOPHAGUS METASTASIS; FEMALE; HUMAN; INFECTION; INOPERABLE CANCER; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; MULTICENTER STUDY; NEUROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; SQUAMOUS CELL CARCINOMA; STOMATITIS; THROMBOCYTOPENIA; VOMITING;

EID: 0031825774     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.524     Document Type: Article

References (10)

1. Ajani JA (1994) Contributions of chemotherapy in the treatment of carcinoma of the esophagus: results and commentary. Semin Oncol 21: 474-482
2. Ajani JA, Ryan B, Rich TA, McMurtrey M, Roth JA, DeCaro L, Levin B and Mountain C (1992) Prolonged chemotherapy for localized squamous carcinoma of the esophagus. Eur J Cancer 28A: 880-884
3. Ajani JA, Ilson DH, Daugherty K, Pazdur R, Lynch PM and Kelsen DP (1994) Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst 86: 1086-1091
4. Ajani JA, Ilson D, Bhalla K, Forastiere A, Padzur R, Martin L, Daugherty K and Kelsen DP (1995) Taxol, cisplatin and 5-FU (TCF): a multi-institutional phase II study in patients with carcinoma of the esophagus. Proc ASCO 14: 203
5. Coia LR (1994) Chemoradiation as primary management of esophageal cancer. Semin Oncol 21: 483-492
6. Glemon KA, O'Reilly SE, Tolcher AW, Camphell C, Bryce C, Ragaz J, Coppin C, Plenderleith IH, Ayers D, McDermott B, Nakashima L, Healey D and Onetto N (1996) Phase I/II trial of hiweekly paclitaxel and cisplatin in the treatment of metastatic breast cancer. J Clin Oncol 14: 1185-1191
7. Hilgenberg AD, Carey RW, Wilkins Jr EW, Choi NC, Mathisen DJ and Grillo HC (1988) Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus. Ann Thor Surg 45: 357-363
8. Kok TC, Van der Gaast A, Dees J for the Rotterdam Oesophageal Tumour Study Group (1996) Cisplatin and etoposide in oesophageal cancer: a phase II study. Br J Cancer 74: 980-984
9. Spiridonidis CH, Laufmann LR, Jones JJ, Gray DJ, Cho CC and Young DC (1996) A phase II evaluation of high dose cisplatin and etoposide in patients with advanced esophageal adenocarcinoma. Cancer 78: 2070-2077
10. Stahl M, Wilke H, Meyer H-J, Preusser P, Berns T, Fink U, Aehterrath W, Knipp H, Harstrick A, Berger M and Schmoll H-J (1994) 5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the esophagus. Eur J Cancer 30A: 325-328